Research And Markets: Lymphoma Drug Pipeline Update 2009

Main Category: Lymphoma / Leukemia / Myeloma
Article Date: 02 Mar 2009 - 3:00 PDT

email to a friend   printer friendly   view / write opinions

Research and Markets has announced the addition of the "Lymphoma Drug Pipeline Update 2009" report to their offering.

Lymphoma is a broad term encompassing a variety of cancers of the lymphatic system. There are today more than 200 therapeutics targeting lymphoma in active development, from early preclinical to marketed drugs. In addition, the accumulated number of ceased drugs over the last three years amount to another 50 drugs.

Lymphoma Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 123 different targets. These targets are further categorized on the CD-ROM by 44 classifications of molecular function and with pathway referrals to BioCarta, KEGG and NetPath. Read more below on how the Lymphoma Drug Pipeline Update is organized.

How May Drug Pipeline Update Be of Use?

- Show investors/board/management that you are right on top of drug development progress in your therapeutic area.
- Find competitors, collaborations partners, M&A candidates etc.
- Jump start competitive drug intelligence operations
- Excellent starting point for worldwide benchmarking
- Compare portfolio and therapy focus with your peers
- Speed up pro-active in-/out licensing strategy work
- Fast and easy way of tracking drugs using search engines; just one click from inside the application and you may search the World Wide Web and PubMed for any drug.
- Drug Pipeline Update is delivered to you as a CD-ROM application, which requires no installation on your computer. Please read more about application features and system requirements below.

For more information visit here.

Research and Markets